|
LYRM7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.56099999998527E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.415600E-03 |
| Stage1-vs-Stage3 |
4.780200E-02 |
| Stage1-vs-Stage4 |
1.184500E-04 |
| Stage2-vs-Stage3 |
1.577190E-04 |
| Stage2-vs-Stage4 |
1.44469999996399E-06 |
| Stage3-vs-Stage4 |
9.326000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.11099995869779E-09 |
| Normal-vs-Asian |
1.63014046705712E-12 |
| Caucasian-vs-AfricanAmerican |
5.180400E-01 |
| Caucasian-vs-Asian |
4.817800E-01 |
| AfricanAmerican-vs-Asian |
9.197200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.519000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
5.856999999998E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.478600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.016400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.154800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.327600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.464800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.271200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.81460000026057E-07 |
| Classical-VS-Follicular |
9.01501095995627E-13 |
| Classical-VS-Other |
6.476400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.62447832963153E-12 |
| Tall-VS-Other |
6.260300E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.620300E-03 |
| Follicular-VS-Normal |
4.65380000091997E-08 |
| Other-VS-Normal |
3.59340000000152E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.41680000456768E-08 |
|
|
